Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Benhamou

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|August 10, 2005
Hepatitis B virus genotypes and extrahepatic manifestationsPatrice Cacoub, David Saadoun, Marc Bourlière, et al.
Journal of Diabetes Science and Technology|September 29, 2022
Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 SystemPierre-Yves Benhamou, Alice Adenis, Yousra Tourki, et al.
Comparative Hepatology|September 25, 2004
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis CThierry Poynard, Françoise Imbert-Bismut, Mona Munteanu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2008
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failureFabien Zoulim, Parviz Parvaz, Patrick Marcellin, et al.
Journal of Diabetes Science and Technology|August 1, 2014
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studiesSophie Borot, Sylvia Franc, Justine Cristante, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapyPatrick Ingiliz, Marc-Antoine Valantin, Claudine Duvivier, et al.
The Journal of Infectious Diseases|June 27, 2013
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trialYves Benhamou, Joseph Moussalli, Vlad Ratziu, et al.
AIDS (London, England)|May 13, 2006
Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patientsStéphanie Dominguez, Jade Ghosn, Marc-Antoine Valantin, et al.
Hepatology (Baltimore, Md.)|February 26, 2005
Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis CMarkus Reiser, Holger Hinrichsen, Yves Benhamou, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|August 10, 2005
Hepatitis B virus genotypes and extrahepatic manifestationsPatrice Cacoub, David Saadoun, Marc Bourlière, et al.
Journal of Diabetes Science and Technology|September 29, 2022
Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 SystemPierre-Yves Benhamou, Alice Adenis, Yousra Tourki, et al.
Comparative Hepatology|September 25, 2004
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis CThierry Poynard, Françoise Imbert-Bismut, Mona Munteanu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2008
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failureFabien Zoulim, Parviz Parvaz, Patrick Marcellin, et al.
Journal of Diabetes Science and Technology|August 1, 2014
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studiesSophie Borot, Sylvia Franc, Justine Cristante, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapyPatrick Ingiliz, Marc-Antoine Valantin, Claudine Duvivier, et al.
The Journal of Infectious Diseases|June 27, 2013
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trialYves Benhamou, Joseph Moussalli, Vlad Ratziu, et al.
AIDS (London, England)|May 13, 2006
Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patientsStéphanie Dominguez, Jade Ghosn, Marc-Antoine Valantin, et al.
Hepatology (Baltimore, Md.)|February 26, 2005
Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis CMarkus Reiser, Holger Hinrichsen, Yves Benhamou, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.
Pageof 17